From the above, we could speculate that RIPK3-mediated necroptosis of tumor cells may promote the activation of various tumor-killing immune cells and enhance the immune cells infiltrating within tumor tissues, thereby enhancing the intratumoral antitumor immune response. This evidence concerns the gene RIPK3 and neoplasm.